New strategies for mobilization of hematopoietic stem cells.

Item

http://www.wikidata.org/entity/Q36429495

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

New strategies for mobilization of hematopoietic stem cells.

@ast

New strategies for mobilization of hematopoietic stem cells.

@en

type

Item

label

New strategies for mobilization of hematopoietic stem cells.

@ast

New strategies for mobilization of hematopoietic stem cells.

@en

prefLabel

New strategies for mobilization of hematopoietic stem cells.

@ast

New strategies for mobilization of hematopoietic stem cells.

@en

P1476

New strategies for mobilization of hematopoietic stem cells.

@en

P2093

Stefan Fruehauf

http://www.w3.org/2001/XMLSchema#string

Timon Seeger

http://www.w3.org/2001/XMLSchema#string

P2860

Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1

Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells.

Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient.

Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance.

CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

P304

375-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14796694.1.3.375

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16556011

http://www.w3.org/2001/XMLSchema#string